Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors

NCT07196579 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Cancer

Interventions

DRUG: KXV01 TCR Lentinvivo Injection

Sponsor

TCRx Therapeutics Co.Ltd

Collaborators

[object Object]